We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
GILD icon
1
Gilead Sciences
GILD
$187B
$187B $150.93 0.83%
ABT icon
2
Abbott
ABT
$175B
$175B $101.29 0.22%
NVO
3
Novo Nordisk
NVO
$171B
$171B $38.80 0.47%
PFE icon
4
Pfizer
PFE
$163B
$163B $28.67 0.92%
DHR icon
5
Danaher
DHR
$158B
$158B $224.49 0.32%
ISRG icon
6
Intuitive Surgical
ISRG
$143B
$143B $405.18 1.42%
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$133B
$133B $526.19 0.73%
BMY icon
8
Bristol-Myers Squibb
BMY
$128B
$128B $62.86 2.21%
CVS icon
9
CVS Health
CVS
$114B
$114B $89.13 4.8%
MDT icon
10
Medtronic
MDT
$113B
$113B $88.64 0.15%
SYK icon
11
Stryker
SYK
$104B
$104B $272.36 0.97%
MCK icon
12
McKesson
MCK
$101B
$101B $866.64 0.31%
GSK icon
13
GSK
GSK
$98.7B
$98.7B $49.24 0.83%
SNY icon
14
Sanofi
SNY
$98.5B
$98.5B $41.11 0.42%
HCA icon
15
HCA Healthcare
HCA
$94.3B
$94.3B $435.61 2.86%
ELV icon
16
Elevance Health
ELV
$85.9B
$85.9B $396.09 0.54%
REGN icon
17
Regeneron Pharmaceuticals
REGN
$81.1B
$81.1B $788.04 1%
MRNA icon
18
Moderna
MRNA
$79.4B
$79.4B $198.88 2.08%
CI icon
19
Cigna
CI
$71.9B
$71.9B $272.01 2.45%
BSX icon
20
Boston Scientific
BSX
$63.7B
$63.7B $43.92 1.7%
TAK icon
21
Takeda Pharmaceutical
TAK
$60.2B
$60.2B $18.86 1.45%
ARGX icon
22
argenx
ARGX
$60B
$60B $959.49 0.28%
NTRA icon
23
Natera
NTRA
$59.5B
$59.5B $412.56 0.92%
COR icon
24
Cencora
COR
$58.6B
$58.6B $306.92 0.95%
CAH icon
25
Cardinal Health
CAH
$51B
$51B $220.22 1.08%
1
2 3 4 5

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 106 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.48T.

The largest by market cap are Gilead Sciences (GILD) at $187B, Abbott (ABT) at $175B and Novo Nordisk (NVO) at $171B.

Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 323 funds opened new positions, taking total fund holders up 194 (10%) quarter-over-quarter.

  • Combined market cap: $4.48T across 106 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Gilead Sciences (GILD), $187B market cap.
  • Most net new fund positions in Q2 2026: CVS Health (CVS), +194 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.